Talking about side effects. This a brand new drug, I would wait some years to take it. The problem is that if you stop taking it you gain the weight back, its not a cure.
Ozempic and Wegovy May Be Linked to Increased Risk of Rare Form of Blindness — but More Research Is Needed
People who take
Ozempic and
Wegovy may have a higher risk of developing a rare eye condition that can cause blindness, according to a new study, but more research is needed.
The study, published July 3 in
JAMA Opthamology, found that patients with diabetes who were prescribed semaglutide — the ingredient in Ozempic and Wegovy — were more than four times more likely to develop a condition called non-arthritic anterior ischemic optic neuropathy, or NAION, as
NBC News,
Reuters and
CNN reported.
In a statement to the news outlets, Novo Nordisk, the company that manufactures Ozempic and Wegovy, said, “Patient safety is a top priority for Novo Nordisk, and we take all reports about adverse events from the use of our medicines very seriously."
NAION is a condition that can cause sudden and permanent blindness that has no known treatment. The new study was prompted by doctors at Mass Eye and Ear after they noted three cases in one week in patients using semaglutide medications, per CNN. Researchers analyzed data and medical records from 16,827 patients in the Boston area between 2017 and 2023.
Still, said researchers, "future study is required to assess causality" between the ingredient semaglutide and NAION.
A study published in JAMA Opthamology on July 3 suggested a potential link between a rare eye condition, non-arthritic anterior ischemic optic neuropathy, or NAION, and diabetes patients who take Ozempic, Wegovy and similar weight-loss drugs — but study authors say more research is needed.
people.com